MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-05-2026
National Research Corporation Current Ratio 2011-2026 | NRC
Annual Current Ratio National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.12 | 1.31 | 1.67 | 2.23 | 2.18 | 1.93 | 0.764 | 0.603 | 1.62 | 1.49 | 1.27 | 1.9 | 1.54 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.23 | 0.603 | 1.51 |
Quarterly Current Ratio National Research Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.12 | 1.18 | 1.28 | 1.31 | 1.36 | 1.51 | - | 1.67 | 1.93 | 2.39 | 2.25 | 2.23 | 2.01 | - | 2.14 | 2.18 | 2.14 | 2.01 | 1.99 | 1.93 | 1.93 | 1.93 | 1.93 | 1.42 | 1.42 | 1.42 | 1.42 | 1.21 | 1.21 | 1.21 | 1.21 | 3.42 | 3.42 | 3.42 | 3.42 | 3.19 | 3.19 | 3.19 | 3.19 | 2.38 | 2.38 | 2.38 | 2.38 | 3.1 | 3.1 | 3.1 | 3.1 | 2.82 | 2.82 | 2.82 | 2.83 | 2.31 | 2.31 | 2.31 | 2.31 | 2.23 | 2.23 | 2.23 | 2.23 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.42 | 1.12 | 2.22 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Biodesix
BDSX
|
1.27 | $ 14.1 | -3.46 % | $ 1.83 B |  USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
1.23 | $ 13.29 | -1.88 % | $ 3.77 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.96 | $ 29.99 | -5.78 % | $ 1.52 B | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
Neuronetics
STIM
|
1.23 | $ 1.44 | 8.27 % | $ 95 M | USA |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
Thermo Fisher Scientific
TMO
|
1.92 | $ 478.51 | -2.12 % | $ 180 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.746 | $ 0.6 | -2.2 % | $ 61.9 M |  Irlanda |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Twist Bioscience Corporation
TWST
|
3.8 | $ 45.31 | -3.08 % | $ 2.71 B | USA |
 |
Co-Diagnostics
CODX
|
10.2 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
Waters Corporation
WAT
|
2.02 | $ 292.64 | -2.64 % | $ 17.4 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 158.44 | -4.05 % | $ 7.85 B | USA |
 |
Exagen
XGN
|
1.43 | $ 2.67 | -4.3 % | $ 57.6 M | USA |
 |
Organovo Holdings
ONVO
|
3.52 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
3.97 | - | -16.95 % | $ 1.54 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.35 | $ 4.65 | 1.31 % | $ 2.5 M | USA |
 |
Personalis
PSNL
|
4.02 | $ 6.68 | -8.76 % | $ 396 M | USA |
 |
PerkinElmer
PKI
|
2.47 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
1.05 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
0.87 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
1.56 | $ 57.44 | -3.32 % | $ 4.32 B | USA |
 |
Motus GI Holdings
MOTS
|
1.59 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.88 | - | - | $ 10.6 B |  Niderland |
 |
Celcuity
CELC
|
1.27 | $ 110.97 | -3.34 % | $ 5.19 B | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
1.94 | $ 6.54 | -0.38 % | $ 273 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 268.45 | 0.03 % | $ 22.3 B | USA |
 |
VolitionRx Limited
VNRX
|
0.265 | $ 0.2 | 3.52 % | $ 19.2 M |  Singapore |
 |
Psychemedics Corporation
PMD
|
2.18 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
4.93 | $ 26.48 | -2.65 % | $ 34.4 M | USA |
 |
CareDx, Inc
CDNA
|
3.75 | $ 17.08 | -2.23 % | $ 910 M | USA |
 |
Quotient Limited
QTNT
|
0.861 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
1.71 | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
0.504 | - | 5.66 % | $ 22.7 M | Britain |